Company to participate in Live Virtual Investor Closing Bell segment today, April 16th?at?4:00 PM ET- Register for the event here OCALA, Fla., April 16, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (N ...
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva," the "Company" "we" or "us"), a late-stage pharmaceutical company developing therapies ...
Clinching their spot in the playoffs for the first time since 2022, the Pittsburgh Penguins have already accomplished more ...
Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria. Approval in CSU for children two to ...
The Trump administration dropped its fiscal 2027 budget request Friday, and the massive document release includes some ...
NPR Global Health and Development Correspondent Fatma Tanis talks about digging into the impact of billions of dollars of US aid being cut from programs around the world.
Through a series of smaller efforts such as solidifying disaster recovery programs, funding low-income home repairs and ...
NORCROSS, Ga., March 31, 2026 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and ...
Recorded Fourth Quarter Revenues of $35.7 Million and Transition Period Revenues of $75.5 Million -- -- Multiple New Programs Signed in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results